Resource

 

 

 

 

 

 

 

 

 

 

 

JV/Alliance/Licence

Hill Dickinson advises Portage Pharmaceuticals on joint venture collaboration with University of Glasgow

12 Feb 2018

Consultant, Michael Corcoran, from Hill Dickinson’s London corporate team has recently advised long-standing Canadian Securities Exchange listed client, Portage Biotech Inc. (OTCQB: PTGEF, Canadian Stock Exchange: PBT.U) (Portage) on its participation in a new joint venture project with the University of Glasgow to develop more effectively targeted drugs to treat chronic conditions including cancer.

Firm Advises on £200 Million Chinese Investment in Cambridge Science Park in UK

12 Feb 2018

A Squire Patton Boggs team, led by London Corporate partner Michelle Chen, has advised client Tus-Holdings Co., Ltd. on a landmark £200 million joint venture with Trinity College, Cambridge. The deal will see a new phase of investment and renewal in Cambridge Science Park, including 350,000 sq ft of office/research space over five new buildings, including a state-of-the-art Biohub, which will be home to laboratories and offices for early stage biotech and medtech companies.

Burges Salmon advises Yeo Valley on partnership with Arla Foods

09 Feb 2018

Burges Salmon has advised Yeo Valley on its partnership with Arla Foods in relation to liquid milk, butter and cheese.

The transaction, which sees Arla Foods Limited acquire Yeo Valley subsidiary Yeo Valley Dairies Limited, will give the farmer-owned dairy cooperative the rights to use the Yeo Valley brand in milk, butter, spreadables and cheese under licence from Yeo Valley.

The Yeo Valley yogurt, ice cream, cream and desserts business will continue to be run independently through Yeo Valley Group, which remains under the ownership of the Mead family.

Firm Advises on £200 Million Chinese Investment in Cambridge Science Park in UK

09 Feb 2018

A Squire Patton Boggs team, led by London Corporate partner Michelle Chen, has advised client Tus-Holdings Co., Ltd. on a landmark £200 million joint venture with Trinity College, Cambridge. The deal will see a new phase of investment and renewal in Cambridge Science Park, including 350,000 sq ft of office/research space over five new buildings, including a state-of-the-art Biohub, which will be home to laboratories and offices for early stage biotech and medtech companies.

Hill Dickinson advises Portage Pharmaceuticals on joint venture collaboration with University of Glasgow

09 Feb 2018

Consultant, Michael Corcoran, from Hill Dickinson’s London corporate team has recently advised long-standing Canadian Securities Exchange listed client, Portage Biotech Inc. (OTCQB: PTGEF, Canadian Stock Exchange: PBT.U) (Portage) on its participation in a new joint venture project with the University of Glasgow to develop more effectively targeted drugs to treat chronic conditions including cancer.

Arnold & Porter Advises Novartis on Licensing Agreement with Spark Therapeutics

09 Feb 2018

Arnold & Porter advised long-time client Novartis on its recent licensing agreement with Spark Therapeutics. The licensing agreement covers development, registration and commercialization rights to voretigene neparvovec in markets outside the US. Voretigene neparvovec, known as Luxturna in the US, received FDA approval on December 19, 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65 gene. Currently there is no existing therapy for this disease outside the US.

Lebanon Completes Successful Offshore Licensing Round

09 Feb 2018

Cleary Gottlieb advised the Ministry of Energy and Water of the Republic of Lebanon, and the Lebanese Petroleum Administration, in connection with its First Offshore Licensing Round.

Exploration and Production Agreements were awarded for two blocks in Lebanon’s exclusive economic zone to a consortium comprising Total, Eni, and Novatek.

The Council of Ministers approved the contracts on December 14, 2017, and a signing ceremony was held in Beirut on February 9, 2018.

Burges Salmon advises Yeo Valley on partnership with Arla Foods

08 Feb 2018

Burges Salmon has advised Yeo Valley on its partnership with Arla Foods in relation to liquid milk, butter and cheese.

The transaction, which sees Arla Foods Limited acquire Yeo Valley subsidiary Yeo Valley Dairies Limited, will give the farmer-owned dairy cooperative the rights to use the Yeo Valley brand in milk, butter, spreadables and cheese under licence from Yeo Valley.

The Yeo Valley yogurt, ice cream, cream and desserts business will continue to be run independently through Yeo Valley Group, which remains under the ownership of the Mead family.

DLA Piper advises Harrison Street on Crosslane joint venture

07 Feb 2018

Global law firm DLA Piper has advised leading real estate investment firm Harrison Real Estate Capital LLC, on its joint venture with Crosslane Property Group UK, a real estate company specialising in purpose built student accommodation (PBSA) across the UK and Continental Europe.

The JV will jointly develop four student accommodation properties totalling 1,267 beds in Leeds, Coventry, Portsmouth and Swansea.